Teva and Allergan Agree to Nationwide Opioid Marketing Settlements

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Teva and Allergan Agree to Nationwide Opioid Marketing Settlements

J.W. Schomisch

December 1, 2022 at 09:36 AM EST

Both Teva Pharmaceutical Industries Ltd. and Allergan, which was acquired by AbbVie in 2020, have finalized nationwide settlement terms of lawsuits over the companies’ promotion and marketing of opioid products. The settlements are with both the working group of States’ Attorneys General and the Multi-District Litigation Plaintiffs’ Executive Committee and involves nearly all... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

Teva and Allergan Agree to Nationwide Opioid Marketing Settlements

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT